Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 09, 2022 Filed Nov 14, 2022 17:59 UTC GrantStock Option (Right to Buy) · Derivative 2,730 $0.00 Strike: $133.74 $0.00
Disclosure

SEC source: 0001225208-22-011622 · doc4.xml · derivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,730

Underlying: Common Stock · 2,730 shares

Expires 2032-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:59 UTC GrantCommon Stock 627 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011622 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,859

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:56 UTC
Zavery AmitDirector
GrantStock Option (Right to Buy) · Derivative 2,730 $0.00 Strike: $133.74 $0.00
Disclosure

SEC source: 0001225208-22-011624 · doc4.xml · derivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,730

Underlying: Common Stock · 2,730 shares

Expires 2032-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:56 UTC
Zavery AmitDirector
GrantCommon Stock 627 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011624 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,841

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:56 UTC GrantStock Option (Right to Buy) · Derivative 2,730 $0.00 Strike: $133.74 $0.00
Disclosure

SEC source: 0001225208-22-011617 · doc4.xml · derivative · entry 2

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,730

Underlying: Common Stock · 2,730 shares

Expires 2032-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:56 UTC GrantCommon Stock 627 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011617 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,982

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:55 UTC GrantStock Option (Right to Buy) · Derivative 2,730 $0.00 Strike: $133.74 $0.00
Disclosure

SEC source: 0001225208-22-011621 · doc4.xml · derivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,730

Underlying: Common Stock · 2,730 shares

Expires 2032-11-09

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 09, 2022 Filed Nov 14, 2022 17:55 UTC GrantCommon Stock 627 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-011621 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,378.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC GrantCommon Stock 78 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010883 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,117

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 12:40 UTC GrantCommon Stock 78 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010888 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,394

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010884 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 491

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC
keller brettDirector
GrantCommon Stock 8 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010885 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,627

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC
keller brettDirector
GrantCommon Stock 28 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010885 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 12:39 UTC GrantCommon Stock 113 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010881 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,850

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:40 UTC
Zavery AmitDirector
GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010889 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,214

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:40 UTC
Zavery AmitDirector
GrantCommon Stock 10 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010889 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,212

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:40 UTC GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010887 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,232

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:40 UTC GrantCommon Stock 2 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010887 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,230

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC GrantCommon Stock 13 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010886 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,751.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC GrantCommon Stock 51 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010886 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,738.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 16:39 UTC GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010882 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,355

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 05, 2022 Filed Aug 17, 2023 22:55 UTC Amendment
Zavery AmitDirector
GrantCommon Stock 7 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-008335 · doc4a.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,224

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 01, 2022 Filed Oct 4, 2022 19:43 UTC
Stingi Richard JohnCorporate VP and CHRO
GrantRestricted Stock Unit · Derivative 1,511 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010657 · doc4.xml · derivative · entry 1

Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,511

Underlying: Common Stock · 1,511 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

F1 · shares: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

F1 · derivative.exercise_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

F1 · derivative.expiration_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

Read SEC document
October 01, 2022 Filed Oct 4, 2022 19:43 UTC
KALENKA ROBERT FCorporate Vice President
GrantRestricted Stock Unit · Derivative 1,511 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010656 · doc4.xml · derivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,511

Underlying: Common Stock · 1,511 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

F1 · shares: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

F1 · derivative.exercise_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

F1 · derivative.expiration_date: Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into Broadridge common stock on April 1, 2025.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 15:09 UTC
keller brettDirector
GrantCommon Stock 170 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010483 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,591

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 15:09 UTC
Zavery AmitDirector
GrantCommon Stock 155 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010486 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,202

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 15:09 UTC GrantCommon Stock 170 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010485 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,228

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 15:09 UTC GrantCommon Stock 192 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010484 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,687.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 35,817 $93.88 Strike: $93.88 $3,362,499.96
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · derivative · entry 11

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,817 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 36,780 $98.31 Strike: $98.31 $3,615,841.80
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · derivative · entry 10

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,780

Underlying: Common Stock · 36,780 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
SaleCommon Stock 1,985 $176.34 $350,034.90
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 5

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · by The KLD 2014 Trust

Disclosed balance after: 0

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.33 - $176.50, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
SaleCommon Stock 64,300 $175.39 $11,277,577.00
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 4

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,169.9949

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.26 - $175.88, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
SaleCommon Stock 8,683 $175.04 $1,519,872.32
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 3

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,469.9949

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 - $175.53, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
Exercise / conversionCommon Stock 35,817 $93.88 $3,362,499.96
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 2

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,152.9949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 26, 2022 Filed Aug 26, 2022 19:39 UTC
DALY RICHARD JDirector · Executive Chairman
Exercise / conversionCommon Stock 36,780 $98.31 $3,615,841.80
Disclosure

SEC source: 0001225208-22-009814 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,335.9949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2022 Filed Aug 19, 2022 20:16 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 4,179 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-22-009684 · doc4.xml · derivative · entry 3

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,179 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2022 Filed Aug 19, 2022 20:16 UTC SaleCommon Stock 3,702 $176.28 $652,576.71
Disclosure

SEC source: 0001225208-22-009684 · doc4.xml · nonDerivative · entry 2

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,809.528

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.18 - $176.38, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 19, 2022 Filed Aug 19, 2022 20:16 UTC Exercise / conversionCommon Stock 4,179 $93.88 $392,324.52
Disclosure

SEC source: 0001225208-22-009684 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,511.528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2022 Filed Aug 17, 2022 13:55 UTC
Matlin LauraVP, Deputy GC and CGO
SaleCommon Stock 2,067 $177.81 $367,539.68
Disclosure

SEC source: 0001225208-22-009614 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,617.696

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.810 - $177.875, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 17, 2022 Filed Aug 17, 2022 18:51 UTC
KALENKA ROBERT FCorporate Vice President
GiftCommon Stock 300 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-009618 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,802.4097

F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 17:56 UTC
Gumbs Keir DCVP and Chief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 12,209 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-009615 · doc4.xml · derivative · entry 3

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,848

Underlying: Common Stock · 12,209 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock.

F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
August 16, 2022 Filed Aug 17, 2022 17:56 UTC
Gumbs Keir DCVP and Chief Legal Officer
Tax withholdingCommon Stock 5,867 $177.32 $1,040,336.44
Disclosure

SEC source: 0001225208-22-009615 · doc4.xml · nonDerivative · entry 2

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,552.22

Read SEC document
August 16, 2022 Filed Aug 17, 2022 17:56 UTC
Gumbs Keir DCVP and Chief Legal Officer
Exercise / conversionCommon Stock 12,209 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-009615 · doc4.xml · nonDerivative · entry 1

Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,419.22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on August 16, 2022 12,209 Restricted Stock Units vested and converted into an equal number of shares of common stock.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 5,399 $0.00 Strike: $67.32 $0.00
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · derivative · entry 10

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,399 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 7,222 $0.00 Strike: $50.95 $0.00
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · derivative · entry 9

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,222 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 5,696 $0.00 Strike: $51.95 $0.00
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · derivative · entry 8

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,696 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 5,000 $179.16 $895,776.50
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 7

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,902

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 4,502 $179.16 $806,557.16
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 6

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,902

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 3,631 $179.16 $650,512.89
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 5

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,404

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:27 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 3,570 $179.16 $639,584.42
Disclosure

SEC source: 0001225208-22-009604 · doc4.xml · nonDerivative · entry 4

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,035

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.86 - $179.75, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.